They have been extended to non-small-cell lung cancer, prostate cancer, colorectal cancer, and others, strongly suggesting that PARP1 may have additional roles beyond repairing damaged bases or SSBs. The gene discussed is PARP1; the disease is non-small cell lung carcinoma.